Neurocrine Biosciences (NBIX) Tops Q3 EPS by 12c

November 3, 2016 6:43 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment